CAMP4 Therapeutics Corporation (CAMP) Company Statistics | The Fly

Search...

/

Dashboard

Charting

KPIs

Stock Screener

ETF Screener

Earnings Calendar

Events Calendar

Syndicate

Street Research

Portfolios

Alert Settings

© 2026 The Fly Inc.

The Fly Cast

Press play to listen

©

CAMP4 Therapeutics Corporation (CAMP) Company Statistics | The Fly

CAMP4 Therapeutics Corporation

· CAMP

Dashboard

Financials

Ratios

Valuation

Statistics

233.218 M

-4.95%

General

Market Cap: $245.37M
Enterprise Value: $155.59M
Shares Outstanding: 51,930,000
Dividend: —
Employees: —
Revenue Per Employee: —

Fundamental Ratios (TTM)

Gross Margin: 77.80%
Operating Margin: -1242.50%
Net Profit Margin: -2543.74%
FCF Margin: -681.21%
ROA: -114.79%
ROE: -314.08%
ROIC: -69.76%
Current Ratio: 4.70
Debt-to-Equity: -3.42
Revenue Per Employee: —

Valuation (TTM)

P/E: —
PEG: —
P/S: 57.01
P/FCF: —
P/B: —
EV/EBITDA: -2.13

Growth

Rev 1Y: 436.50%
Rev 1Y Fwd Est: 107.95%
Rev 3Y (CAGR): —
Rev 5Y (CAGR): —
Rev 10Y (CAGR): —
EPS 1Y: —
EPS 1Y Fwd Est: —
EPS 3Y (CAGR): —
EPS 5Y (CAGR): —
EPS 10Y (CAGR): —

Income Statement (TTM)

Revenue: $4.22M
Gross Margin: 77.80%
Operating Expenses: $55.66M
Operating Income: -$52.38M
Net Profit: -$107.24M

Balance Sheet

Cash and Equivalents: $87.13M
Working Capital: $70.89M
Total Assets: $93.43M
Net Debt: -$84.76M
Total Liabilities: $94.12M
Total Equity: -$693K

Cash Flow Statement (TTM)

Cash Flow from Operations: -$28.59M
Cash Flow from Investing: -$93K
Cash Flow from Financing: $76.03M
Free Cash Flow: -$28.72M
Capital Expenditures: $129K